WELL Health Technologies Corp.
WHTCF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $261,782 | $356,673 | $294,137 | $193,240 |
| % Growth | -26.6% | 21.3% | 52.2% | – |
| Cost of Goods Sold | $161,800 | $197,934 | $176,665 | $152,082 |
| Gross Profit | $99,982 | $158,739 | $117,472 | $41,158 |
| % Margin | 38.2% | 44.5% | 39.9% | 21.3% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $84,375 | $66,652 | $62,341 |
| SG&A Expenses | $76,083 | $107,238 | $90,199 | $84,624 |
| Sales & Mktg Exp. | $0 | $22,863 | $23,547 | $22,283 |
| Other Operating Expenses | $0 | $24,363 | $19,630 | $20,435 |
| Operating Expenses | $76,083 | $131,601 | $109,829 | $105,059 |
| Operating Income | $23,899 | $27,138 | $7,643 | -$63,901 |
| % Margin | 9.1% | 7.6% | 2.6% | -33.1% |
| Other Income/Exp. Net | -$18,939 | -$4,217 | -$50,758 | $13,119 |
| Pre-Tax Income | $4,961 | $22,921 | -$43,115 | -$50,782 |
| Tax Expense | $6,866 | $5,923 | -$1,229 | -$19,054 |
| Net Income | $2,995 | $12,151 | -$46,574 | -$13,003 |
| % Margin | 1.1% | 3.4% | -15.8% | -6.7% |
| EPS | 0.012 | 0.048 | -0.19 | -0.053 |
| % Growth | -75.4% | 125.3% | -258.5% | – |
| EPS Diluted | 0.012 | 0.048 | -0.19 | -0.051 |
| Weighted Avg Shares Out | 253,663 | 253,275 | 250,489 | 246,764 |
| Weighted Avg Shares Out Dil | 257,218 | 253,275 | 250,489 | 254,652 |
| Supplemental Information | – | – | – | – |
| Interest Income | $246 | $340 | $519 | $500 |
| Interest Expense | $12,910 | $9,324 | $10,941 | $8,564 |
| Depreciation & Amortization | $19,041 | $25,395 | $19,546 | $20,963 |
| EBITDA | $37,017 | $60,906 | -$12,628 | -$21,255 |
| % Margin | 14.1% | 17.1% | -4.3% | -11% |